// App-Quantinova.ai

: Oral mucosal IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral candidiasis

Researchers

Presenter

  • Felix E.Y. Aggor

Principal Investigators

  • Timothy Break

  • Giraldina Trevejo-Nunez

  • Natasha Whibley

  • Rachel D. Bailey

  • Daniel H Kaplan

  • Julian R. Naglik

  • Wei Shan

  • Amol C. Shetty

  • Carrie McCracken

  • Scott K. Durum

  • Partha S. Biswas

  • Vincent M. Bruno

  • Jay K Kolls

  • Michail S Lionakis

  • Sarah L. Gaffen

Medical Centers

  • Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom, United Kingdom

  • Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD.

  • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA

  • Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute, NIH, Frederick MD, USA

  • Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

  • Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, United States,

  • Department of Pathology, University of Pittsburgh, School of Medicine S- BST, Pittsburgh, PA, PA.

  • Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, United States

  • Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda Maryland, USA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Interleukin-22

  • Interleukin-23

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved